tm logo
AGN1
Live/Pending
NEW APPLICATION - ASSIGNED TO EXAMINER

assigned to examiner

on 28 Sep 2024

Last Applicant/ Owned by

Suite 100

Rockville

MD

20855

Serial Number

98461614 filed on 21st Mar 2024

Registration Number

N/A

Correspondent Address

Matthew J. Smith

Matthew J. Smith Polsinelli PC

Kansas City, MO 64114-0310

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

AGN1

Bone void fillers consisting of biological materials; pharmaceutical products for treatment of osteoporosis, osteopenia, osteoarthritis, osteotraumatic injuries, degenerative bone diseases and joint diseases; pharmaceutical preparations for altering bone density; medications for the prevention or treatment of osteoporosis, osteopenia, osteoarthritis, osteotraumatic injuries, degenerative bone dise Read More

Classification Information


Class [005]
Pharmaceutical Products


Bone void fillers consisting of biological materials; pharmaceutical products for treatment of osteoporosis, osteopenia, osteoarthritis, osteotraumatic injuries, degenerative bone diseases and joint diseases; pharmaceutical preparations for altering bone density; medications for the prevention or treatment of osteoporosis, osteopenia, osteoarthritis, osteotraumatic injuries, degenerative bone diseases and joint diseases; pharmaceutical preparations for preventing or treating of osteoporosis, osteopenia, osteoarthritis, osteotraumatic injuries, degenerative bone diseases and joint diseases; pharmaceutical preparations for use in enhancing cardiovascular health and bone health


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98461614

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 076857-TBD

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
28th Sep 2024ASSIGNED TO EXAMINER
17th Aug 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21st Mar 2024NEW APPLICATION ENTERED